Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.596
-0.014 (-2.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed
MTNB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 4 | 7.28 | 4.79 | 6.83 | 21.03 | Upgrade
|
| Short-Term Investments | - | - | 8.97 | 21.93 | 28.59 | Upgrade
|
| Cash & Short-Term Investments | 4 | 7.28 | 13.76 | 28.76 | 49.62 | Upgrade
|
| Cash Growth | -45.10% | -47.05% | -52.18% | -42.04% | -15.43% | Upgrade
|
| Prepaid Expenses | 0.03 | 0.69 | 1.74 | 5.72 | 1.32 | Upgrade
|
| Other Current Assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Total Current Assets | 4.08 | 8.03 | 15.54 | 34.53 | 50.99 | Upgrade
|
| Property, Plant & Equipment | 0.67 | 2.16 | 5.01 | 5.73 | 5.78 | Upgrade
|
| Goodwill | - | - | 1.34 | 1.34 | 1.34 | Upgrade
|
| Long-Term Deferred Charges | 2.26 | 2.26 | 3.02 | 3.02 | 3.02 | Upgrade
|
| Other Long-Term Assets | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | Upgrade
|
| Total Assets | 7.21 | 12.64 | 25.1 | 44.82 | 61.33 | Upgrade
|
| Accounts Payable | 0.32 | 0.1 | 0.51 | 0.62 | 0.94 | Upgrade
|
| Accrued Expenses | 0.45 | 1.81 | 1.45 | 2.29 | 1.92 | Upgrade
|
| Current Portion of Leases | 0.7 | 0.77 | 0.66 | 0.57 | 0.56 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.72 | 0.03 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.09 | 0.9 | Upgrade
|
| Total Current Liabilities | 1.46 | 2.67 | 2.62 | 4.29 | 4.35 | Upgrade
|
| Long-Term Leases | 0.66 | 2.13 | 2.9 | 3.56 | 4.14 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.26 | 0.26 | 0.34 | 0.34 | 0.34 | Upgrade
|
| Total Liabilities | 2.38 | 5.05 | 5.86 | 8.18 | 8.83 | Upgrade
|
| Common Stock | 0 | 0 | - | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 215.62 | 207.41 | 195.04 | 190.07 | 184.25 | Upgrade
|
| Retained Earnings | -210.79 | -199.82 | -175.57 | -152.63 | -131.63 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.22 | -0.82 | -0.15 | Upgrade
|
| Total Common Equity | 4.83 | 7.59 | 19.25 | 36.64 | 52.49 | Upgrade
|
| Shareholders' Equity | 4.83 | 7.59 | 19.25 | 36.64 | 52.49 | Upgrade
|
| Total Liabilities & Equity | 7.21 | 12.64 | 25.1 | 44.82 | 61.33 | Upgrade
|
| Total Debt | 1.35 | 2.89 | 3.56 | 4.12 | 4.7 | Upgrade
|
| Net Cash (Debt) | 2.65 | 4.39 | 10.2 | 24.64 | 44.92 | Upgrade
|
| Net Cash Growth | -39.75% | -56.96% | -58.60% | -45.15% | -18.22% | Upgrade
|
| Net Cash Per Share | 0.48 | 0.90 | 2.35 | 5.68 | 10.69 | Upgrade
|
| Filing Date Shares Outstanding | 6.41 | 5.09 | 4.35 | 4.35 | 4.34 | Upgrade
|
| Total Common Shares Outstanding | 6.41 | 5.09 | 4.35 | 4.35 | 4.33 | Upgrade
|
| Working Capital | 2.61 | 5.36 | 12.92 | 30.25 | 46.65 | Upgrade
|
| Book Value Per Share | 0.75 | 1.49 | 4.43 | 8.43 | 12.14 | Upgrade
|
| Tangible Book Value | 4.83 | 7.59 | 17.91 | 35.3 | 51.16 | Upgrade
|
| Tangible Book Value Per Share | 0.75 | 1.49 | 4.12 | 8.12 | 11.83 | Upgrade
|
| Machinery | - | 1.54 | 2.46 | 2.31 | 1.64 | Upgrade
|
| Leasehold Improvements | 0.17 | 0.99 | 1.16 | 1.16 | 0.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.